| X23-10-ZQ619 |
EGFR-HER2 inhibitor AV412, Purity ≥98%
|
|
| X23-10-ZQ622 |
EGFR-HER2 inhibitor EGFR-IN-3, Purity ≥98%
|
|
| X24-05-ZQ632 |
EGFR-HER2 inhibitor PD168393, Purity ≥98%
|
|
| X24-05-ZQ633 |
EGFR-HER2 inhibitor CGP-52411, Purity ≥98%
|
|
| X24-05-ZQ634 |
EGFR-HER2 inhibitor ARRY-543, Purity ≥98%
|
|
| X24-05-ZQ635 |
EGFR-HER2 inhibitor AG-1517, Purity ≥98%
|
|
| X24-05-ZQ636 |
EGFR-HER2 inhibitor CO-1686, Purity ≥98%
|
|
| X24-05-ZQ637 |
EGFR-HER2 inhibitor Poziotinib, Purity ≥98%
|
|
| X24-05-ZQ638 |
EGFR-HER2 inhibitor CL-387785, Purity ≥98%
|
|
| X24-05-ZQ639 |
EGFR-HER2 inhibitor Tyrphostin AG 183, Purity ≥98%
|
|
| X24-05-ZQ640 |
EGFR inhibitor, Purity ≥98%
|
|
| X24-05-ZQ641 |
EGFR-HER2 inhibitor AZD-9291, Purity ≥98%
|
|
| X24-05-ZQ642 |
EGFR-HER2 inhibitor Icotinib hydrochloride, Purity ≥98%
|
|
| X24-05-ZQ643 |
EGFR-HER2 inhibitor CNX-2006, Purity ≥98%
|
|
| X24-05-ZQ644 |
EGFR-HER2 inhibitor Epertinib, Purity ≥98%
|
|
| X24-05-ZQ645 |
EGFR-HER2 inhibitor Icotinib, Purity ≥98%
|
|
| X24-05-ZQ646 |
EGFR-HER2 inhibitor ASP8273, Purity ≥98%
|
|
| X24-05-ZQ647 |
EGFR-HER2 inhibitor EGF816, Purity ≥98%
|
|
| X24-05-ZQ648 |
Epidermal growth factor receptor peptide (985-996), Purity ≥98%
|
|
| X24-05-ZQ649 |
EGFR-HER2 inhibitor Compound 56, Purity ≥98%
|
|
| X24-05-ZQ650 |
EGFR-HER2 inhibitor Afatinib dimaleate, Purity ≥98%
|
|
| X24-05-ZQ651 |
EGFR-HER2 inhibitor Erlotinib mesylate, Purity ≥98%
|
|
| X24-05-ZQ652 |
EGFR-HER2 inhibitor Gefitinib hydrochloride, Purity ≥98%
|
|
| X24-05-ZQ653 |
EGFR-HER2 inhibitor Vandetanib trifluoroacetate, Purity ≥98%
|
|
| X24-05-ZQ654 |
EGFR-HER2 inhibitor D-69491, Purity ≥98%
|
|
| X24-05-ZQ655 |
EGFR-HER2 inhibitor WHI-P180, Purity ≥98%
|
|
| X24-05-ZQ656 |
EGFR-HER2 inhibitor AZ5104, Purity ≥98%
|
|
| X24-05-ZQ657 |
EGFR-HER2 inhibitor AZD3759, Purity ≥98%
|
|
| X24-05-ZQ658 |
EGFR-HER2 inhibitor AG-18, Purity ≥98%
|
|
| X24-05-ZQ659 |
EGFR-HER2 inhibitor DM1-SMCC, Purity ≥98%
|
|
| X24-05-ZQ660 |
EGFR-HER2 inhibitor EAI045, Purity ≥98%
|
|
| X24-05-ZQ661 |
EGFR-HER2 inhibitor Anlotinib, Purity ≥98%
|
|
| X24-05-ZQ662 |
EGFR-HER2 inhibitor PD158780, Purity ≥98%
|
|
| X24-05-ZQ663 |
EGFR-HER2 inhibitor TX1-85-1, Purity ≥98%
|
|
| X24-05-ZQ664 |
EGFR-HER2 inhibitor ARRY-380, Purity ≥98%
|
|
| X24-05-ZQ665 |
EGFR-HER2 inhibitor NSC 228155, Purity ≥98%
|
|
| X24-05-ZQ666 |
EGFR-HER2 inhibitor Avitinib, Purity ≥98%
|
|
| X24-05-ZQ667 |
EGFR-HER2 inhibitor Lazertinib, Purity ≥98%
|
|
| X24-05-ZQ668 |
EGFR-HER2 inhibitor Pyrotinib racemate, Purity ≥98%
|
|
| X24-05-ZQ669 |
EGFR-HER2 inhibitor Tyrphostin AG-528, Purity ≥98%
|
|
